StemCell Institute KK engages in stem cell banking business. It deals with stem cell contract management, research, and development. The company was founded on August 5, 1999 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company